Observational × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Myeloid × Clear all ACROBAT
Active not recruiting
307 enrolled
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Recruiting
30 enrolled
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Recruiting
99,999 enrolled
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recruiting
2,000 enrolled
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
Active not recruiting
153 enrolled
Biology Studies of Hematologic Cancers
Enrolling by invitation
550 enrolled
Muscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell Transplant
Active not recruiting
144 enrolled
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Recruiting
15,000 enrolled
Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study
Active not recruiting
350 enrolled
HOPE
Recruiting
10 enrolled
Muscle Dysfunction in Patients With Haematological Diseases
Active not recruiting
216 enrolled
Registry of Older Patients With Cancer
Recruiting
3,000 enrolled
Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies
Completed
81 enrolled
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
Active not recruiting
9,000 enrolled
SARS-CoV-2 Donor-Recipient Immunity Transfer
Completed
26 enrolled
Chemobrain
Completed
45 enrolled 10 charts
Ex Vivo Drug Sensitivity Testing and Mutation Profiling
Completed
25 enrolled
SPACE2
Unknown
150 enrolled
(ANSWer)
Completed
119 enrolled
T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
Terminated
150 enrolled
Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer
Terminated
1,000 enrolled
Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation
Terminated
56 enrolled 12 charts
Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant
Completed
304 enrolled
Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant
Completed
36 enrolled
Blood Samples From Patients on a Clinical Trial to CINV During HSCT
Terminated
9 enrolled
Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone
Completed
41 enrolled
Comparative Evaluation of Results of Allogeneic Hematopoietic Stem Cells Versus Ponatinib in CML Patients Carrying a Mutation T315I
Completed
184 enrolled
Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML)
Terminated
88 enrolled
Structural Imaging and Cognitive Functions in Adult Stem Cell Transplant Recipients Treated With Chemotherapy Alone or in Combination With Radiotherapy
Completed
66 enrolled
Study of Natural Killer Cells in Bone Marrow and Blood Samples From Patients With and Without Hematologic Cancer
Terminated
34 enrolled
Transplant-Related Mortality in Patients Undergoing a Peripheral Blood Stem Cell Transplantation or an Umbilical Cord Blood Transplantation
Completed
178 enrolled
Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant
Terminated
24 enrolled
Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer
Terminated
48 enrolled
Early Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow Transplant
Withdrawn
Study of Information Received About Fertility and Infertility in Patients Who Have Finished Treatment for Cancer
Unknown
96 enrolled
Pilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic Malignancies
Terminated
15 enrolled
Studying Fentanyl in Patients With Cancer
Terminated
2 enrolled
Observational Study of Iron Overload in Stem Cell Transplantation
Completed
45 enrolled
Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia
Completed
44 enrolled